表紙:迅速微生物検査の世界市場 (~2026年):製品 (試薬&キット・自動同定システム・PCR・質量分析)・手法 (成長・核酸・生存率)・用途 (臨床診断・製薬・環境)・地域別
市場調査レポート
商品コード
1018255

迅速微生物検査の世界市場 (~2026年):製品 (試薬&キット・自動同定システム・PCR・質量分析)・手法 (成長・核酸・生存率)・用途 (臨床診断・製薬・環境)・地域別

Rapid Microbiology Testing Market by Product (Reagents, Kits, Automated Identification System, PCR, Mass Spectrometry), Method (Growth, Nucleic Acid, Viability), Applications (Clinical Diagnosis, Pharma, Environmental) - Global Forecast to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 268 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.65円
迅速微生物検査の世界市場 (~2026年):製品 (試薬&キット・自動同定システム・PCR・質量分析)・手法 (成長・核酸・生存率)・用途 (臨床診断・製薬・環境)・地域別
出版日: 2021年07月08日
発行: MarketsandMarkets
ページ情報: 英文 268 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の迅速微生物検査の市場規模は予測期間中9.4%のCAGRで推移し、2021年の42億米ドルから、2026年には67億米ドルの規模に成長すると予測されています。

技術の進歩、感染症や癌の発生率の増加、感染症の早期発見への関心の高まり、R&Dへの資金提供の増加などの要因が同市場の成長を推進しています。一方で、高額な資本投資と低い費用対効果、不利な規制や償還シナリオなどの課題が市場成長を妨げる主な要因となっています。

製品別では、試薬・キットの部門が予測期間中最大の成長を示すと予測されています。感染症の早期発見への関心が高まりが同部門の成長を牽引しています。また、用途別では、食品・飲料検査の部門が最大のCAGRを示す見通しです。感染症や癌の発生率の増加が同部門の成長を牽引しています。

当レポートでは、世界の迅速微生物検査の市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、技術・特許の分析、市場規模の推移・予測、製品・手法・用途・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19の影響
  • 価格分析
  • 特許分析
  • 貿易分析
  • バリューチェーン分析
  • サプライチェーン分析
  • エコシステム分析
  • ポーターのファイブフォース分析
  • PESTLE分析
  • 規制状況
  • 技術分析
  • ディスラプティブ技術

第6章 市場分析・予測:製品別

  • 機器
    • 自動微生物同定・抗菌薬感受性検査システム
    • 質量分析計
    • 生物発光・蛍光ベース検出システム
    • PCRシステム
    • サイトメーター
    • アクティブエアサンプラー
    • その他
  • 試薬・キット
    • 滅菌試薬・キット
    • その他
  • 消耗品

第7章 市場分析・予測:手法別

  • 成長ベース検査
  • 細胞成分ベース検査
  • 核酸ベース検査
  • 生存率ベース検査
  • その他

第8章 市場分析・予測:用途別

  • 臨床診断
  • 食品・飲料検査
  • 製薬・生物学的薬物検査
  • 環境検査
  • 化粧品・パーソナルケア製品検査
  • 研究
  • その他

第9章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 主要企業の戦略
  • 主要企業の収益シェア分析
  • 市場シェア分析
  • 企業評価クアドラント
  • 新興企業・中小企業の競合リーダーシップマッピング
  • 競合ベンチマーキング
  • 競合シナリオ

第11章 企業プロファイル

  • 主要企業
    • BIOMERIEUX SA
    • DANAHER CORPORATION
    • BECTON, DICKINSON AND COMPANY
    • ABBOTT LABORATORIES
    • THERMO FISHER SCIENTIFIC INC.
    • MERCK KGAA
    • SARTORIUS AG
    • BRUKER CORPORATION
    • QUIDEL CORPORATION
    • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • NEOGEN CORPORATION
  • 他の有力企業
    • DON WHITLEY SCIENTIFIC
    • RAPID MICRO BIOSYSTEMS
    • VIVIONE BIOSCIENCES, LLC
    • GRADIENTECH
    • RQMICRO AG
    • BACTEST LTD.
    • COLIFAST
    • SEROSEP LTD.
    • BIOSENSIA LTD.
    • SOLUS SCIENTIFIC SOLUTIONS LTD.
    • LUBIOSCIENCE GMBH
    • EUROCLONE SPA
    • CORDX
    • R-BIOPHARM AG

第12章 付録

目次
Product Code: MD 6602

The global rapid microbiology testing market is projected to reach USD 6.7 billion by 2026 from USD 4.2 billion in 2021, at a CAGR of 9.4% during the forecast period. Market growth is driven by factors such as the technological advancements in rapid microbiology testing, Increasing incidence of infectious disease and cancer,increased focus on the early detection of infectious disease and increased funding on R&D.On the other hand, the high capital investments and low cost-benefit ratio and unfavorable regulatory and reimbursement scenarios are the major factors hampering the growth of this market.

"The reagents and kits segment accounted for the highest growth rate in therapid microbiology testing market, by product, during the forecast period"

The rapid microbiology testing market is segmented instruments, reagents and kits and consumables based on product. In 2020, the reagents and kits segment accounted for the highest growth rate in the rapid microbiology testing market.The increased focus on the early detection on infectious disease is a major factor contributing to the growth of this segment.

"Food and beverage testing segment accounted for the highest CAGR"

Based on applications, the rapid microbiology testing market is segmented intoclinical disease diagnosis, food and beverage testing, pharmaceutican and biological drug testing, environmental testing, cosmetics and personal care products testing, research applications and other applications. In 2020, the food and beverage testing segment accounted for the highest growth rate. This can be attributed to theincrease incidence of infectious disease and cancer of rapid microbiology testingmarket to serve a large patient pool.

"Asia Pacific: The fastest-growing regionrapid microbiology testing market"

The global rapid microbiology testing market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period.Factors such as the technological advancements, increased funding on R&D, increasing government efforts to increase awareness about early disease detection, expansion of private-sector hospitals to rural areas in various APAC countries, and the presence of high-growth markets in the region are driving the growth of the rapid microbiology testing market in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%,and Tier 3 -30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America -51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and the Middle East & Africa - 4%

Lists of Companies Profiled in the Report:

  • Abbott Laboratories, Inc. (US)
  • Becton, Dickinson and Company (US)
  • BioMerieux SA (France)
  • Bruker Corporation (US)
  • Charles River Laboratories International, Inc. (US)
  • Danaher Corporation (US)
  • Merck KGaA (Germany)
  • NEOGEN Corporation (US)
  • Quidel Corporation (US)
  • Sartorius AG (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • Don Whitley Scientific Limited (UK)
  • Rapid Micro Biosystems, Inc. (US)
  • Vivione Biosciences, LLC (US)
  • Gradientech (Sweden)
  • Rqmicro AG (Switzerland)
  • Bactest Ltd. (US)
  • Colifast (Norway)
  • Serosep Ltd. (Ireland)
  • Biosensia (Ireland)
  • Solus Scientific Solutions Ltd. (Scotland)
  • LubioScience GmbH (Scotland
  • EurocloneSpA (Italy)
  • CorDx (US)
  • R-Biopharm AG (Germany

Research Coverage:

This report provides a detailed picture of the global rapid microbiology testing market. It aims at estimating the size and future growth potential of the market across different segments, such as product,method, applications,and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall rapid microbiology testing market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 RAPID MICROBIOLOGY TESTING MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 2 RAPID MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
    • FIGURE 4 RAPID MICROBIOLOGY TESTING MARKET: BOTTOM-UP APPROACH
    • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 6 RAPID MICROBIOLOGY TESTING MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 GROWTH RATE ASSUMPTIONS
  • 2.7 LIMITATIONS
  • 2.8 RISK ASSESSMENT
  • 2.9 COVID-19 HEALTH ASSESSMENT
  • 2.10 COVID-19 ECONOMIC ASSESSMENT
  • 2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
  • 2.12 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE RAPID MICROBIOLOGY TESTING MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 10 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 11 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 RAPID MICROBIOLOGY TESTING MARKET OVERVIEW
    • FIGURE 14 RISING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH
  • 4.2 RAPID MICROBIOLOGY TESTING MARKET SHARE, BY PRODUCT, 2021 VS. 2026
    • FIGURE 15 INSTRUMENTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
  • 4.3 RAPID MICROBIOLOGY TESTING MARKET SHARE, BY METHOD, 2021 VS. 2026
    • FIGURE 16 GROWTH-BASED RAPID MICROBIOLOGY TESTING SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • 4.4 RAPID MICROBIOLOGY TESTING MARKET SHARE, BY APPLICATION, 2021 VS. 2026
    • FIGURE 17 CLINICAL DISEASE DIAGNOSIS IS THE LARGEST APPLICATION SEGMENT OF RAPID MICROBIOLOGY TESTS
  • 4.5 RAPID MICROBIOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE RAPID MICROBIOLOGY TESTING MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 RAPID MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of infectious diseases and cancer
      • 5.2.1.2 Technological advancements in rapid microbiology testing
      • 5.2.1.3 Increased funding for R&D
      • 5.2.1.4 Increased focus on the early detection of infectious diseases
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High capital investments and low cost-benefit ratio
      • 5.2.2.2 Unfavorable regulatory and reimbursement scenarios
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Operational barriers
  • 5.3 IMPACT OF COVID-19 ON THE RAPID MICROBIOLOGY TESTING MARKET
    • 5.3.1 GLOBAL TREND IN THE SARS-COV-2 RAPID DIAGNOSTICS MARKET
  • 5.4 PRICING ANALYSIS
    • TABLE 1 PRICES OF RAPID MICROBIOLOGY TESTS (2021)
  • 5.5 PATENT ANALYSIS
  • 5.6 TRADE ANALYSIS
    • 5.6.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
    • TABLE 2 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 3 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016-2020 (USD MILLION)
  • 5.7 VALUE CHAIN ANALYSIS
    • FIGURE 20 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES
  • 5.8 SUPPLY CHAIN ANALYSIS
    • FIGURE 21 DISTRIBUTION-A STRATEGY PREFERRED BY PROMINENT COMPANIES
  • 5.9 ECOSYSTEM ANALYSIS OF THE RAPID MICROBIOLOGY TESTING MARKET
    • FIGURE 22 RAPID MICROBIOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS
  • 5.10 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 RAPID MICROBIOLOGY TESTING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.10.1 THREAT OF NEW ENTRANTS
    • 5.10.2 THREAT OF SUBSTITUTES
    • 5.10.3 BARGAINING POWER OF BUYERS
    • 5.10.4 BARGAINING POWER OF SUPPLIERS
    • 5.10.5 DEGREE OF COMPETITION
  • 5.11 PESTLE ANALYSIS
  • 5.12 REGULATORY LANDSCAPE
    • 5.12.1 NORTH AMERICA
      • 5.12.1.1 US
      • 5.12.1.2 Canada
    • 5.12.2 EUROPE
    • 5.12.3 ASIA PACIFIC
      • 5.12.3.1 Japan
      • 5.12.3.2 India
      • 5.12.3.3 China
    • 5.12.4 LATIN AMERICA
      • 5.12.4.1 Brazil
      • 5.12.4.2 Mexico
    • 5.12.5 MIDDLE EAST
    • 5.12.6 AFRICA
  • 5.13 TECHNOLOGY ANALYSIS
  • 5.14 DISRUPTIVE TECHNOLOGIES IN THE RAPID MICROBIOLOGY TESTING MARKET
    • 5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR THE RAPID MICROBIOLOGY TESTING MARKET
    • FIGURE 23 REVENUE SHIFT FOR THE RAPID MICROBIOLOGY TESTING MARKET

6 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 5 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 6 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
  • 6.2 INSTRUMENTS
    • TABLE 7 KEY PRODUCTS IN THE RAPID MICROBIOLOGY INSTRUMENTS MARKET
    • TABLE 8 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 9 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 10 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 11 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.2.1 AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS
      • 6.2.1.1 Ease of use as compared to conventional identification processes is the major factor supporting the growth of this segment
    • TABLE 12 RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 13 RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY REGION, 2020-2026 (USD MILLION)
    • 6.2.2 MASS SPECTROMETERS
      • 6.2.2.1 Mass spectrometry methods provide rapid results for microbial identification within a few minutes
    • TABLE 14 RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 15 RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY REGION, 2020-2026 (USD MILLION)
    • 6.2.3 BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS
      • 6.2.3.1 Unwanted detection of non-microbial ATP is one of the major disadvantages associated with this technique
    • TABLE 16 RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 17 RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY REGION, 2020-2026 (USD MILLION)
    • 6.2.4 PCR SYSTEMS
      • 6.2.4.1 Standard PCR, real-time PCR, and qPCR are the common PCR techniques used for rapid microbial testing
    • TABLE 18 RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 19 RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY REGION, 2020-2026 (USD MILLION)
    • 6.2.5 CYTOMETERS
      • 6.2.5.1 Ability to detect viable organisms to support market growth
    • TABLE 20 RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 21 RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY REGION, 2020-2026 (USD MILLION)
    • 6.2.6 ACTIVE AIR SAMPLERS
      • 6.2.6.1 Rapid active air samplers are convenient and easy to use and offer more sensitive and complete results in real-time
    • TABLE 22 RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 23 RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY REGION, 2020-2026 (USD MILLION)
    • 6.2.7 OTHER INSTRUMENTS
    • TABLE 24 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 25 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY REGION, 2020-2026 (USD MILLION)
  • 6.3 REAGENTS & KITS
    • TABLE 26 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 27 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 28 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 29 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.3.1 STERILITY REAGENTS & KITS
      • 6.3.1.1 Increasing adoption of BET assays to propel market growth
    • TABLE 30 RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 31 RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY REGION, 2020-2026 (USD MILLION)
    • 6.3.2 OTHER REAGENTS & KITS
    • TABLE 32 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 33 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY REGION, 2020-2026 (USD MILLION)
  • 6.4 CONSUMABLES
    • 6.4.1 DEVELOPMENT OF AUTOMATED ZONE READERS AND DISPENSERS TO DRIVE MARKET GROWTH
    • TABLE 34 RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 35 RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2020-2026 (USD MILLION)

7 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD

  • 7.1 INTRODUCTION
    • TABLE 36 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 37 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 38 TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY TESTING METHODS
  • 7.2 GROWTH-BASED RAPID MICROBIOLOGY TESTING
    • 7.2.1 GROWTH-BASED RAPID MICROBIOLOGY TESTING IS THE LARGEST METHOD SEGMENT
    • TABLE 39 GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 40 GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 7.3 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING
    • 7.3.1 THIS METHOD OFFERS A HIGH LEVEL OF SENSITIVITY, ACCURACY, AND SPECIFICITY
    • TABLE 41 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 42 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 7.4 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING
    • 7.4.1 NUCLEIC ACID-BASED METHODS TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
    • TABLE 43 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 44 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 7.5 VIABILITY-BASED RAPID MICROBIOLOGY TESTING
    • 7.5.1 NEAR REAL-TIME DETECTION AND IMPROVED ACCURACY ARE SOME OF THE ADVANTAGES DRIVING THE ADOPTION OF THIS SEGMENT
    • TABLE 45 VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 46 VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 7.6 OTHER RAPID MICROBIOLOGY TESTING METHODS
    • TABLE 47 OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 48 OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY REGION, 2020-2026 (USD MILLION)

8 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 49 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 50 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
  • 8.2 CLINICAL DISEASE DIAGNOSIS
    • 8.2.1 HIGH BURDEN OF INFECTIOUS DISEASES AND HAIS TO PROPEL MARKET GROWTH
    • TABLE 51 RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 52 RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY REGION, 2020-2026 (USD MILLION)
  • 8.3 FOOD & BEVERAGE TESTING
    • 8.3.1 FOOD & BEVERAGE TESTING IS THE FASTEST-GROWING APPLICATION SEGMENT IN THE RAPID MICROBIOLOGY TESTING MARKET
    • TABLE 53 RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 54 RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY REGION, 2020-2026 (USD MILLION)
  • 8.4 PHARMACEUTICAL & BIOLOGICAL DRUG TESTING
    • 8.4.1 IMPROVED REGULATORY SCENARIO FOR DRUG DEVELOPMENT TO SUPPORT MARKET GROWTH
    • TABLE 55 RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 56 RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY REGION, 2020-2026 (USD MILLION)
  • 8.5 ENVIRONMENTAL TESTING
    • 8.5.1 GROWING FOCUS ON ENVIRONMENTAL MONITORING WILL BOOST THE GROWTH OF THIS SEGMENT
    • TABLE 57 RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 58 RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2020-2026 (USD MILLION)
  • 8.6 COSMETICS & PERSONAL CARE PRODUCTS TESTING
    • 8.6.1 RAPID MICROBIOLOGY TESTING IS WIDELY USED IN THESE INDUSTRIES TO DETERMINE THE PRESENCE OF MICROBES IN THE MANUFACTURING PROCESS
    • TABLE 59 RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 60 RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING, BY REGION, 2020-2026 (USD MILLION)
  • 8.7 RESEARCH APPLICATIONS
    • 8.7.1 INCREASING USE OF MICROBIOLOGY TESTING SERVICES BY ACADEMIC & RESEARCH INSTITUTES TO DRIVE MARKET GROWTH
    • TABLE 61 RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 62 RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020-2026 (USD MILLION)
  • 8.8 OTHER APPLICATIONS
    • TABLE 63 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 64 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2026 (USD MILLION)

9 RAPID MICROBIOLOGY TESTING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 65 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 66 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 24 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
    • TABLE 67 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 68 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 69 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 70 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 71 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 72 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 73 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 74 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Adoption of technologically advanced products in the US to favor market growth
    • TABLE 75 US: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 76 US: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 77 US: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 78 US: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 79 US: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 80 US: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 81 US: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 82 US: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Favorable environment for R&D and rising incidence of infectious diseases to drive the rapid microbiology testing market in Canada
    • TABLE 83 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 84 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 85 CANADA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 86 CANADA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 87 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 88 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 89 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 90 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 91 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 92 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 93 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 94 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 95 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 96 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 97 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 98 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany is the largest & fastest-growing market for rapid microbiology testing in Europe
    • TABLE 99 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 100 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 101 GERMANY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 102 GERMANY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 103 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 104 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 105 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 106 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 9.3.2 FRANCE
      • 9.3.2.1 Rising R&D expenditure to drive market growth
    • TABLE 107 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 108 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 109 FRANCE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 110 FRANCE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 111 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 112 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 113 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 114 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Increasing investments and funding by the government to drive the market growth in the UK
    • TABLE 115 UK: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 116 UK: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 117 UK: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 118 UK: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 119 UK: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 120 UK: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 121 UK: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 122 UK: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 9.3.4 REST OF EUROPE
    • TABLE 123 ROE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 124 ROE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 125 ROE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 126 ROE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 127 ROE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 128 ROE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 129 ROE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 130 ROE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 25 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
    • TABLE 131 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 133 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 134 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 135 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 136 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 137 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 138 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 Increasing funding for R&D to drive market growth
    • TABLE 139 CHINA: KEY MACROINDICATORS
    • TABLE 140 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 141 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 142 CHINA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 143 CHINA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 144 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 145 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 146 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 147 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Rising geriatric population in Japan to support market growth
    • TABLE 148 JAPAN: KEY MACROINDICATORS
    • TABLE 149 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 150 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 151 JAPAN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 152 JAPAN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 153 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 154 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 155 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 156 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 High incidence of infectious diseases in the country to drive the adoption of rapid microbiology testing products
    • TABLE 157 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 158 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 159 INDIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 160 INDIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 161 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 162 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 163 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 164 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 165 ROAPAC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 166 ROAPAC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 167 ROAPAC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 168 ROAPAC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 169 ROAPAC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 170 ROAPAC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 171 ROAPAC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 172 ROAPAC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 INCREASING PER CAPITA HEALTHCARE EXPENDITURE TO SUPPORT MARKET GROWTH
    • TABLE 173 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 174 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 175 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 176 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 177 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 178 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH
    • TABLE 179 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 180 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 181 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016-2019 (USD MILLION)
    • TABLE 182 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020-2026 (USD MILLION)
    • TABLE 183 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 184 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE RAPID MICROBIOLOGY TESTING MARKET
    • TABLE 185 OVERVIEW OF STRATEGIES DEPLOYED BY KEY RAPID MICROBIOLOGY TESTING MANUFACTURING COMPANIES
  • 10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE RAPID MICROBIOLOGY TESTING MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 27 RAPID MICROBIOLOGY TESTING MARKET SHARE, BY KEY PLAYER (2020)
    • TABLE 186 RAPID MICROBIOLOGY TESTING MARKET: DEGREE OF COMPETITION
  • 10.5 COMPANY EVALUATION QUADRANT
    • 10.5.1 LIST OF EVALUATED VENDORS
    • 10.5.2 STARS
    • 10.5.3 EMERGING LEADERS
    • 10.5.4 PERVASIVE PLAYERS
    • 10.5.5 PARTICIPANTS
    • FIGURE 28 RAPID MICROBIOLOGY TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
  • 10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020)
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 DYNAMIC COMPANIES
    • FIGURE 29 RAPID MICROBIOLOGY TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020
  • 10.7 COMPETITIVE BENCHMARKING
    • FIGURE 30 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE RAPID MICROBIOLOGY TESTING MARKET
    • TABLE 187 COMPANY PRODUCT FOOTPRINT
    • TABLE 188 COMPANY GEOGRAPHICAL FOOTPRINT
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 PRODUCT LAUNCHES & REGULATORY APPROVALS
    • TABLE 189 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
    • 10.8.2 DEALS
    • TABLE 190 KEY DEALS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 11.1.1 BIOMERIEUX SA
    • TABLE 191 BIOMERIEUX: BUSINESS OVERVIEW
    • FIGURE 31 BIOMERIEUX SA: COMPANY SNAPSHOT (2020)
    • 11.1.2 DANAHER CORPORATION
    • TABLE 192 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.3 BECTON, DICKINSON AND COMPANY
    • TABLE 193 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 33 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
    • 11.1.4 ABBOTT LABORATORIES
    • TABLE 194 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 34 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
    • 11.1.5 THERMO FISHER SCIENTIFIC INC.
    • TABLE 195 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
    • FIGURE 35 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
    • 11.1.6 MERCK KGAA
    • TABLE 196 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2020)
    • 11.1.7 SARTORIUS AG
    • TABLE 197 SARTORIUS AG: BUSINESS OVERVIEW
    • FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT (2020)
    • 11.1.8 BRUKER CORPORATION
    • TABLE 198 BRUKER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 38 BRUKER CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.9 QUIDEL CORPORATION
    • TABLE 199 QUIDEL CORPORATION: BUSINESS OVERVIEW
    • FIGURE 39 QUIDEL CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.10 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • TABLE 200 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW
    • FIGURE 40 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.11 NEOGEN CORPORATION
    • TABLE 201 NEOGEN CORPORATION: BUSINESS OVERVIEW
    • FIGURE 41 NEOGEN CORPORATION: COMPANY SNAPSHOT (2020)
  • 11.2 OTHER PLAYERS
    • 11.2.1 DON WHITLEY SCIENTIFIC
    • TABLE 202 DON WHITLEY SCIENTIFIC: BUSINESS OVERVIEW
    • 11.2.2 RAPID MICRO BIOSYSTEMS
    • TABLE 203 RAPID MICRO BIOSYSTEMS: BUSINESS OVERVIEW
    • 11.2.3 VIVIONE BIOSCIENCES, LLC
    • TABLE 204 VIVIONE BIOSCIENCES, LLC: BUSINESS OVERVIEW
    • 11.2.4 GRADIENTECH
    • TABLE 205 GRADIENTECH: BUSINESS OVERVIEW
    • 11.2.5 RQMICRO AG
    • TABLE 206 RQMICRO AG: BUSINESS OVERVIEW
    • 11.2.6 BACTEST LTD.
    • TABLE 207 BACTEST LTD.: BUSINESS OVERVIEW
    • 11.2.7 COLIFAST
    • TABLE 208 COLIFAST: BUSINESS OVERVIEW
    • 11.2.8 SEROSEP LTD.
    • TABLE 209 SEROSEP LTD.: BUSINESS OVERVIEW
    • 11.2.9 BIOSENSIA LTD.
    • TABLE 210 BIOSENSIA LTD.: BUSINESS OVERVIEW
    • 11.2.10 SOLUS SCIENTIFIC SOLUTIONS LTD.
    • TABLE 211 SOLUS SCIENTIFIC SOLUTIONS LTD.: BUSINESS OVERVIEW
    • 11.2.11 LUBIOSCIENCE GMBH
    • TABLE 212 LUBIOSCIENCE GMBH: BUSINESS OVERVIEW
    • 11.2.12 EUROCLONE SPA
    • TABLE 213 EUROCLONE SPA: BUSINESS OVERVIEW
    • 11.2.13 CORDX
    • TABLE 214 CORDX: BUSINESS OVERVIEW
    • 11.2.14 R-BIOPHARM AG
    • TABLE 215 R-BIOPHARM AG: BUSINESS OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS